Dexcel Pharma Technologies Ltd.
CIK 1720007 · last filed 2022-11-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.98M
Companies
5
Total Filings
12
Lifetime Open-Market Net
$57.64M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. (ROIVW) Delisted | 10%+ Owner | 102,849,443 | $2.75 | $282.84M | $60.00M | 1 | 2022-11-14 |
| PLX | 10%+ Owner | 4,494,820 | $2.22 | $9.98M | -$4.18M | 1 | 2021-06-03 |
| Intec Pharma Ltd. (NTEC) Delisted | 10%+ Owner | 4,344,897 | $9.63 | $41.84M | -$563.3K | 1 | 2020-02-04 |
| Urovant Sciences Ltd. (UROV) Delisted | 10%+ Owner | 22,841,809 | $16.24 | $370.95M | $2.38M | 6 | 2019-06-14 |
| ABUS | 10%+ Owner | — | $4.55 | — | $0 | 2 | 2018-01-16 |
Recent Filings · Page 2 of 2
12 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-16 | ABUS | Buy (P) | — | $0 | EDGAR |
| 2017-10-18 | ABUS | Buy (P) | — | $0 | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.